Study on the Safety, Tolerance and Pharmacokinetics of Phenlarmide Tablets

NCT04693039 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Phenlarmide
DRUG: Placebo

Sponsor

Shijiazhuang Yiling Pharmaceutical Co. Ltd

Collaborators

[object Object]